JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 27, 2006; DOI: 10.1124/jpet.106.105163


0022-3565/06/3182-476-483$20.00
JPET 318:476-483, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.105163v1
318/2/476    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jung, U. J.
Right arrow Articles by Choi, M.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jung, U. J.
Right arrow Articles by Choi, M.-S.

ENDOCRINE AND DIABETES

Antihyperglycemic and Antioxidant Properties of Caffeic Acid in db/db Mice

Un Ju Jung, Mi-Kyung Lee, Yong Bok Park, Seon-Min Jeon, and Myung-Sook Choi

Institute of Genetic Engineering (U.J.J., S.-M.J.) and Departments of Genetic Engineering (Y.B.P.) and Food Science and Nutrition (M.-S.C.), Kyungpook National University, Daegu, Korea; and Division of Food Sciences (M.-K.L.), Sunchon National University, Jeonnam, Korea

This study investigated the blood glucose-lowering effect and antioxidant capacity of caffeic acid in C57BL/KsJ-db/db mice. Caffeic acid induced a significant reduction of the blood glucose and glycosylated hemoglobin levels than the control group. The plasma insulin, C-peptide, and leptin levels in caffeic acid group were significantly higher than those of the control group, whereas the plasma glucagon level was lower. Increased plasma insulin by caffeic acid was attributable to an antidegenerative effect on the islets. Caffeic acid also markedly increased glucokinase activity and its mRNA expression and glycogen content and simultaneously lowered glucose-6-phosphatase and phosphoenolpyruvate carboxykinase activities and their respective mRNA expressions, accompanied by a reduction in the glucose transporter 2 expression in the liver. In contrast to the hepatic glucose transporter 2, adipocyte glucose transporter 4 expression was greater than the control group. In addition, caffeic acid significantly increased superoxide dismutase, catalase, and glutathione peroxidase activities and their respective mRNA levels, while lowering the hydrogen peroxide and thiobarbituric acid reactive substances levels in the erythrocyte and liver of db/db mice. These results indicate that caffeic acid exhibits a significant potential as an antidiabetic agent by suppressing a progression of type 2 diabetic states that is suggested by an attenuation of hepatic glucose output and enhancement of adipocyte glucose uptake, insulin secretion, and antioxidant capacity.


Received for publication March 24, 2006
Accepted April 25, 2006.

Address correspondence to: Dr. Myung-Sook Choi, Department of Food Science and Nutrition, Kyungpook National University, 1370 San-Kyuk Dong Puk-Ku, 702-701, Daegu, Korea. E-Mail: mschoi{at}knu.ac.kr




This article has been cited by other articles:


Home page
ptjournalHome page
L. Stehno-Bittel
Intricacies of Fat
Physical Therapy, November 1, 2008; 88(11): 1265 - 1278.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Rogoff, J. W. Ryder, K. Black, Z. Yan, S. C. Burgess, D. R. McMillan, and P. C. White
Abnormalities of Glucose Homeostasis and the Hypothalamic-Pituitary-Adrenal Axis in Mice Lacking Hexose-6-Phosphate Dehydrogenase
Endocrinology, October 1, 2007; 148(10): 5072 - 5080.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.